| IOL | Iron overload |
| NTDT | Non-transfusion dependent thalassemia |
| ICT | Iron chelation therapy |
| TDT | Transfusion-dependent thalassemia |
| β-TI | β-thalassemia intermedia |
| GDF-15 | Growth differentiation factor-15 |
| TGF-β | Transforming growth factor-β |
| SF | Serum ferritin |
| LIC | Liver iron concentration |
| dw | dry weight |
| DFO | Deferoxamine |
| DFP | Deferiprone |
| DFX | Deferasirox |
| DT | Dispersible tablet |
| FCT | Film-coated tablet |
| EMA | European Medicines Agency |
| TIF | Thalassemia International Federation |
| GI | Gastrointestinal |
| PRO | Patient-reported outcomes |
| TMPRSS6 | Transmembrane protein serine 6 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.